Would you ever treat the internal mammary lymph nodes in a high risk patient who is axillary sentinel lymph node negative?

I would consider in a high risk node negative patient- ex. age < 40, ER-/Triple negative, LVSI + with inner quadrant disease. However, I would look at dosimetry achieved and only include if I can meet both IM coverage constraints and heart and lung constraints.